Key result
Perioperative management of patients with drug-eluting stents requiring noncardiac surgery remains controversial, with strategies including delaying surgery, continuing aspirin, or bridging therapy.
No takes yet. Share an insight, caveat, or question.
Management of patients with DES requiring noncardiac surgery remains controversial, with strategies like delaying surgery, continuing aspirin, or bridging therapies aiming to balance the competing risks of stent thrombosis and bleeding.
Abdel‐Karim et al. (2011) conducted an editorial in Patients with drug-eluting stents (DES) requiring noncardiac surgery. Perioperative management strategies (e.g., antiplatelet continuation, bridging therapy) was evaluated. Perioperative management of patients with drug-eluting stents requiring noncardiac surgery remains controversial, with strategies including delaying surgery, continuing aspirin, or bridging therapy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: